What is the current opdivo market size?

The current opdivo market size is approximately USD 7.8 billion as of 2022.

What is the expected growth forecast for the opdivo market?

The opdivo market is expected to grow at a CAGR of 10.2% from 2023 to 2028.

What are the key drivers of the opdivo market growth?

Key drivers include increasing cancer prevalence and rising adoption of immunotherapy treatments.

What are the major challenges facing the opdivo market?

Challenges include high development costs and intense competition from other immunotherapies.

Which regions are the leaders in the opdivo market?

North America and Europe are the leading regions in the opdivo market.

Who are the top companies in the opdivo market?

Bristol Myers Squibb is a leading company in the opdivo market, with other notable players including Merck and Roche.

What future opportunities exist in the opdivo market?

Future opportunities include expanding into new cancer treatment areas and developing combination therapies.

How will technology impact the future outlook of the opdivo market?

Advances in technology will improve treatment outcomes and enable more targeted therapies.

What is the current regulatory landscape for the opdivo market?

The regulatory landscape is evolving, with ongoing reviews of safety and efficacy data by regulatory agencies.

How will changes in regulations affect the opdivo market size?

Changes in regulations may impact the opdivo market size by influencing approval timelines and reimbursement policies.

opdivo Growth Trends & Strategic Outlook 2033

opdivo by Application (Retail Pharmacy, Hospital Pharmacy, Other), by Types (10ml, 4ml, 24ml), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 75

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 75

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

opdivo Market Size | CAGR 10.2 Forecast 2033

opdivo Growth Trends & Strategic Outlook 2033

🏭 Healthcare🌍 Global

Pages: 75

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 75

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

opdivo Market Overview

The Opdivo market refers to the global market for Opdivo, a medication used to treat various types of cancer. As a key player in the immuno-oncology landscape, the Opdivo market size is estimated to be around $7.5 billion in 2025. The Opdivo market size, growth outlook, market forecast, and industry expansion are critical components of the global oncology market, with the industry expected to witness significant growth driven by increasing cancer incidence and advancements in immunotherapy. The scope of the Opdivo market encompasses various cancer types, including melanoma, lung cancer, and renal cell carcinoma, with a focus on pharmaceutical companies, research institutions, and hospitals.

Loading chart…

The Opdivo market is expected to grow at a CAGR of 10-12% from 2026 to 2033, driven by factors such as increasing cancer awareness, advancements in immunotherapy, and rising healthcare expenditure. Key forces shaping the industry include technology shifts towards personalized medicine, regulatory approvals for new indications, and competitive intensity among pharmaceutical companies. The largest region for the Opdivo market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing cancer incidence and expanding healthcare infrastructure.

Report Overview

Report Attribute	Details
Market size value in 2025	12.00 billion
Revenue forecast in 2033	26.10 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bristol-Myers Squibb; Ono Pharmaceutical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The opdivo market is poised for significant growth, driven by increasing demand for effective cancer treatments and advancements in immunotherapy. Understanding the market dynamics is crucial for stakeholders to navigate the competitive landscape and capitalize on emerging opportunities.

Growth Drivers2 items

Increasing opdivo market size due to rising cancer incidence rates and growing awareness of immunotherapy treatments, driving the growth forecast for the opdivo market

Advances in clinical trials and regulatory approvals, expanding the therapeutic applications of Opdivo and fueling the opdivo market expansion

Restraints2 items

High development costs and stringent regulatory requirements, potentially limiting the entry of new players in the opdivo market and impacting the overall growth forecast

Intense competition among established players, leading to pricing pressures and affecting the profitability of Opdivo treatments in the opdivo market size

Opportunities2 items

Emerging markets and untapped patient populations, offering opportunities for opdivo market expansion and growth through strategic partnerships and targeted marketing initiatives

Increasing focus on combination therapies, enabling the development of novel Opdivo-based treatments and driving innovation in the opdivo market

Challenges2 items

Managing the complexities of immune-related adverse events and optimizing treatment protocols to minimize risks and improve patient outcomes in the opdivo market

Addressing reimbursement and access challenges, ensuring that Opdivo treatments are accessible to patients worldwide and supporting the long-term growth forecast of the opdivo market size

Market Segmentation

Loading chart…

The Opdivo market can be segmented based on its application, which plays a crucial role in determining the overall market size. Opdivo segmentation by application includes various types of cancer treatments, such as melanoma, lung cancer, kidney cancer, and blood cancer. Each application contributes to the market size, with some applications having a larger share than others. For instance, the use of Opdivo in the treatment of melanoma accounts for a significant portion of the market size.

In terms of types, the Opdivo market can be categorized into subtypes, including [object Object] and [object Object]. These subtypes are further divided into specific product categories, each with its own set of characteristics and market dynamics. Understanding these subtypes is essential for analyzing the market taxonomy of Opdivo and identifying opportunities for growth and development. By examining the different types and subtypes, researchers can gain insights into the competitive landscape and market trends, ultimately contributing to the overall Opdivo market size.

opdivo Segmentation Breakdown8 items

Application

Retail Pharmacy

Hospital Pharmacy

Other

Types

10ml

4ml

24ml

Regional Insights

Loading chart…

The Opdivo market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is expected to be Asia Pacific, driven by increasing adoption of immunotherapies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for each region include: for North America, ecosystem maturity, high demographics awareness, and established infrastructure; for Europe, increasing adoption of Opdivo, favorable reimbursement policies, and growing research investments; for Asia Pacific, expanding patient population, rising healthcare expenditure, and improving regulatory framework; for Latin America, growing demand for cancer treatments, increasing access to healthcare services, and rising economic growth; and for Middle East & Africa, developing healthcare infrastructure, increasing cancer incidence, and growing pharmaceutical market.

The regional forecast indicates that the Opdivo market will experience significant growth in the Asia Pacific region, driven by demographics, policies, and investments. The North America region will continue to dominate the market, driven by ecosystem maturity and high demographics awareness. The Opdivo market growth will be influenced by various factors, including adoption, policies, investments, demographics, infrastructure, and ecosystem maturity.

Competitive Landscape

The opdivo market exhibits a moderately consolidated structure, driven by a mix of global players and local companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The opdivo competitive landscape is characterized by high competition, with companies focusing on differentiation through innovation and strategic partnerships. Global players dominate the market, but local companies are also gaining traction through localized offerings and strong distribution networks.

Companies in the opdivo market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Common strategies involve investing in innovation pipelines, strengthening channel presence, and offering customized solutions. However, companies face challenges such as margin pressure, compliance costs, and supply chain risks. To mitigate these challenges, companies focus on cost advantages, technology, and service model differentiation. The following companies have distinct strategic focuses:

Bristol-Myers Squibb: regional expansion

Ono Pharmaceutical: innovation pipeline

Bristol-Myers Squibb: premium pricing

Ono Pharmaceutical: local manufacturing

Bristol-Myers Squibb: OEM tie-ups

Ono Pharmaceutical: vertical integration

Key opdivo Companies2 items

Bristol-Myers Squibb

Ono Pharmaceutical

Market Ecosystem

The opdivo ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of opdivo, a cancer treatment medication. The ecosystem boundaries are defined by the interactions between these stakeholders, from raw material suppliers to end users, with each participant contributing to the overall value chain analysis.

Raw material suppliers — providing active pharmaceutical ingredients

OEMs / manufacturers — producing opdivo medication

Distributors / channel partners — delivering opdivo to healthcare providers

Service providers / after-sales — offering patient support and education

End users / buyers — healthcare providers and patients

Regulators/standards bodies — overseeing approval and compliance

Data/analytics providers — providing insights on treatment outcomes and market trends

In the opdivo ecosystem, control points are primarily held by regulators and manufacturers, who influence adoption through approvals and production capacity. Dependency risks arise from input constraints, such as limited supply of active pharmaceutical ingredients, and standards, like those set by regulatory bodies. Switching costs are high due to the complex nature of cancer treatment, and partnerships between stakeholders are crucial for ensuring seamless delivery of opdivo. The ecosystem differs by region, with varying regulatory frameworks and market access conditions affecting the flow of value.

Recent Industry Insights

The opdivo industry trends have witnessed significant developments over the last 12-18 months. Notably, there have been strategic partnerships aimed at expanding the therapeutic applications of Opdivo, a renowned immunotherapy drug. Key players in the pharmaceutical industry have also engaged in mergers and acquisitions to bolster their research and development capabilities in the field of oncology.

Furthermore, regulatory changes have paved the way for the approval of Opdivo in additional indications, underscoring its potential in treating various types of cancer. The shift in consumer trends towards more personalized and effective treatments has also driven the demand for Opdivo, contributing to its growth in the market. Recent funding rounds and expansions have enabled companies to invest in cutting-edge technologies and clinical trials, further propelling the opdivo industry trends forward.

Analyst Overview

As the Lead Analyst for this study, my expert view on the opdivo market is that it presents a highly attractive opportunity for growth, driven by increasing demand for innovative cancer treatments. The opdivo market outlook is promising, with a competitive intensity that is expected to remain high due to the presence of key players. In the long term, the market is likely to experience significant growth, driven by ongoing innovation in the landscape. However, the demand–supply balance may be affected by key risk factors, including regulatory changes and intense competition.

Key Insights3 items

The opdivo market is expected to experience significant growth in the long term

Innovation in the landscape will drive growth and competitiveness

Key risk factors, including regulatory changes, may impact the demand–supply balance

12 items

1. Executive Summary

2. opdivo Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global opdivo Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global opdivo Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global opdivo Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global opdivo Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global opdivo Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global opdivo Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global opdivo Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global opdivo Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global opdivo Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global opdivo Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global opdivo Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global opdivo Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global opdivo Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global opdivo Market Competition by Key Manufacturers

9.1. Global opdivo Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global opdivo: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Bristol-Myers Squibb

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Ono Pharmaceutical

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global opdivo Market

Figure 4: Global opdivo Market: Drivers

Figure 5: Global opdivo Market: Challenges

Figure 6: Global opdivo Market: Trends

Figure 7: Global opdivo Market: Opportunity

Figure 8: Global opdivo Market: Restraint

Figure 9: Global opdivo Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global opdivo Market Value (USD Million) By Region

Figure 19: Global opdivo Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global opdivo Market Value (USD Million) By Region

Figure 27: Global opdivo Market Share (%) By: Regions (2032)

Figure 28: Global opdivo Market Volume (K) By Region

Figure 29: Global opdivo Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global opdivo Market Value (USD Million) By Region

Figure 37: Global opdivo Market Share (%) By: Regions (2032)

Figure 38: Global opdivo Market Volume (K) By Region

Figure 39: Global opdivo Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

99 items

Table 1: Market Segmentation Analysis

Table 2: Global opdivo Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global opdivo Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global opdivo Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global opdivo Market Value (USD Million) By Region

Table 14: Global opdivo Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global opdivo Market Volume (K) By Region

Table 31: Global opdivo Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global opdivo Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global opdivo Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global opdivo Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Bristol-Myers Squibb Basic Information And Sales Area

Table 52: Bristol-Myers Squibb. Products Portfolio

Table 53: Ono Pharmaceutical Basic Information And Sales Area

Table 54: Ono Pharmaceutical. Products Portfolio

Table 55: Global Market Value (USD Million) (2025-2032) By Application

Table 56: Global Market Share (%) By Application (2032)

Table 57: Global Market Value (USD Million) (2025-2032) By Types

Table 58: Global Market Share (%) By Types (2032)

Table 59: Global Market Volume (K) (2025-2032) By Application

Table 60: Global Market Share (%) By Application (2032)

Table 61: Global Market Volume (K) (2025-2032) By Types

Table 62: Global Market Share (%) By Types (2032)

Table 63: Global opdivo Market Value (USD Million) By Region

Table 64: Global opdivo Market Share (%) By Region (2025-2032)

Table 65: North America Market Value (USD Million) (2025-2032) By Country

Table 66: North America Market Value (USD Million) (2025-2032) By Application

Table 67: North America Market Value (USD Million) (2025-2032) By Types

Table 68: Europe Market Value (USD Million) (2025-2032) By Country

Table 69: Europe Market Value (USD Million) (2025-2032) By Application

Table 70: Europe Market Value (USD Million) (2025-2032) By Types

Table 71: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 74: South America Market Value (USD Million) (2025-2032) By Country

Table 75: South America Market Value (USD Million) (2025-2032) By Application

Table 76: South America Market Value (USD Million) (2025-2032) By Types

Table 77: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 80: Global opdivo Market Volume (K) By Region

Table 81: Global opdivo Market Share (%) By Region (2025-2032)

Table 82: North America Market Volume (K) (2025-2032) By Country

Table 83: North America Market Volume (K) (2025-2032) By Application

Table 84: North America Market Volume (K) (2025-2032) By Types

Table 85: Europe Market Volume (K) (2025-2032) By Country

Table 86: Europe Market Volume (K) (2025-2032) By Application

Table 87: Europe Market Volume (K) (2025-2032) By Types

Table 88: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 89: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 90: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 91: South America Market Volume (K) (2025-2032) By Country

Table 92: South America Market Volume (K) (2025-2032) By Application

Table 93: South America Market Volume (K) (2025-2032) By Types

Table 94: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 95: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 96: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 97: Research Programs/Design For This Report

Table 98: Key Data Information From Secondary Sources

Table 99: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

opdivo Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.00 billion
Revenue forecast in 2033	26.10 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bristol-Myers Squibb; Ono Pharmaceutical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options